Main Sessions

Session 9 - New Drug Treatment and Technology

Sunday 17 May
11.00 – 13.00

Venue: Apollon

Chairpersons: E. Stefansson ICELAND; E. Zrenner GERMANY

11.00	D. Wong UK Neuroprotection for the inner retina
11.15	J. Sahel FRANCE RdCVF for retinal degenerations
11.30	E. Zrenner GERMANY Monitoring therapeutic success by refined electrophysiological protocols
11.45	V. Chong UK Monocyte therapy for AMD
12.00	A. Gandorfer GERMANY Plasmin and other vitreolytic agents
12.15	C. Pournaras SWITZERLAND Strategies for improvement of the retinal blood flow
12.30	M. Paques FRANCE Novel strategies for reducing macular edema in vein occlusions
12.45	E. Stefánsson ICELAND Cyclodextrin nanoparticles for drug delivery to the retina
13.00	End of session